{"nct_id":"NCT02983604","title":"GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer","status":"TERMINATED","status_verified_date":"2019-07","start_date":"2017-01-10","start_date_type":"ACTUAL","primary_completion_date":"2018-07-19","primary_completion_date_type":"ACTUAL","completion_date":"2018-07-19","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GILD"]}